VAERS Explorer
Back to explore

Report #2838348

Received Apr 28, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
—
Recovered
Not recovered
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
RVXROTAVIRUS (NO BRAND NAME)UNKNOWN MANUFACTURERUNKUNK—

Symptoms (1)

Cough

Symptom narrative

still have the cough; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of cough in a patient who received RSVPreF3 adjuvanted (RSV vaccine) for prophylaxis. On an unknown date, the patient received RSV vaccine. On an unknown date, an unknown time after receiving RSV vaccine, the patient experienced cough (Verbatim: still have the cough). The outcome of the cough was not resolved. It was unknown if the reporter considered the cough to be related to RSV vaccine. It was unknown if the company considered the cough to be related to RSV vaccine. Additional Information: GSK Receipt Date: 23-APR-2025 This case was reported by a patient via interactive digital media. The patient did had RSV vaccine and it helped and wasn't so severe but still had the cough and was still coughing but if didn't get the vaccine, sure it would be worse.